Physalaemin-like immunoreactivity from human lung small cell carcinoma: isocratic reversed-phase HPLC analysis of the chemically modified peptide.
D000818:Animals; D018288:Carcinoma, Small Cell / Q000032:analysis*; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007705:Kinins / Q000302:isolation & purification*; D008175:Lung Neoplasms / Q000032:analysis*; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D010803:Physalaemin / Q000302:isolation & purification*; D011863:Radioimmunoassay; D014183:Transplantation, Heterologous
D007705:Kinins; D010803:Physalaemin